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Abstract 
We analyze an Ebola epidemic using Susceptible-Infected-Recovered 
(S-I-R), deterministic and stochastic models. The models include two 
stages for the infectious class, a recovery class, and a quarantined 
class. The stochastic model was analyzed using simulations. We re-
port on factors such as epidemic size, mean time to extinction, and 
the number of fatalities under a wide set of parameters. An increase 
in the quarantine rate will reduce the size of an epidemic. However, 
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it will not reduce the mean time to extinction of the epidemic. As 
you quarantine symptomatic infectives at a high rate, the individuals 
in the asymptomatic stage of infection will mostly spread the disease. 
As there is a greater difference between per capita infectivity rates, 
the epidemic size also increases. 
1 The Ebola Virus 
1.1 Understanding Viral Hemorrhagic Fevers 
Viral Hemorrhagic Fevers (VHF) are characterized by a particular group of 
illnesses. These illnesses are caused by a distinct family of viruses, a number 
of which are geographically restricted. Their natural hosts are rodents and 
arthropods. The illnesses can range from relatively mild to very severe, 
often causing death(1]. All forms of the disease begin with fevers, head 
aches, cold sweats and muscle aches. As the disease progresses, complications 
might occur. These complications include blood clot failure which can result 
in bleeding from various orifices of the body, vomiting, kidney problems, 
and shock. The four distinct virus families that cause VHF are filoviruses, 
arenaviruses, flaviviruses and bunyaviruses(2]. 
Ebola Hemorrhagic Fever is caused by the Ebola Virus which belongs 
to the filovirous family ( Filoviridae). Filoviridae viruses appear thin and 
filamentous when viewed under an electron microscope. The Ebola virus 
usually appears as a "b" , a "U," or circular shaped organism (see Figure 1). 
Figure 1: The Ebola Virus: Taken from the Center for Disease Control and 
Prevention (CDC) World- Wide Web page. Original photo of the virus was 
magnified 160, 000 times. 
The natural host of the virus is lmknown at this point in time. However, 
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there are four known strains of the Ebola Virus which can affect Homo sapi-
ens or non-human primates (monkeys and chimpanzees). Each strain has a 
name that resembles the geographical location at which the virus was first 
recognized. The outbreaks initially occured in Zaire, Sudan, Reston. There 
was an individual in the Ivory-Coast who was infected with this strain, but 
there was no outbreak. Depending on the strain, this often fatal disease can 
kill between 50% and 90% of the people infected. Outbreaks of Ebola hem-
orrhagic fever usually lead to epidemics as a result of improper handling of 
infected patients[4]. 
1.2 Symptoms 
Ebola hemorrhagic fever is composed of various symptoms. However, in the 
early stages of infection, there is an incubation period where the infective 
is asymptomatic. This incubation period can range from 2 to 14 days after 
infection. The time that the virus remains in this incubation stage depends 
on the method of infection. If the virus comes in direct contact with the 
bloodstream (such as sharing needles with those infected) then the incuba-
tion period will be shorter than other less direct forms of contact (such as 
sneezing on someone). After infection, an individual might experience any 
combination of the following symptoms: headache, chills, loss of appetite, 
weakness, muscle ache, fever, sore throat, malaise, and fatigue. As the in-
fection progresses, infectives experience nausea, vomiting, diarrhea, sporadic 
rashes all over the body, chest pain, uncontrollable blood loss, conjunctivitis 
(eye inflammation), and death, usually from shock. Other symptoms that 
occur include internal bleeding, liver failure, and kidney failure[4]. 
1. 3 Treatment 
There is no known cure, treatment, or vaccination for the Ebola virus. Re-
searchers have been trying to develop a treatment to prevent the spread of 
Ebola. However, the host of the virus is unknown, hence, studying the virus 
for a cure has been very difficult. Presently, the only way to prevent the 
spread of the virus is to quarantine those that have been infected and inform 
people who are caring for the infectives about proper sanitation and barrier 
methods(4]. Quarantine plays an important part in preventing non-infected 
individuals from exposure to bodily fluids of infected individuals such as 
vomit, urine, and stool. In fact, the Center for Disease Control publishes 
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documents that advise on proper quarantine measures[1]. 
1.4 Description of Ebola Subtypes 
1.4.1 Ebola-Zaire 
Ebola-Zaire is the first documented occurence of the virus. It is the deadliest 
of the four Ebola subtypes. This particular strain carries a killing percentage 
of approximately 90% of those infected. Ebola-Zaire affects both human and 
non-human primates. In 1976, the first outbreak occured in Yambuku, Zaire 
and surrounding areas. At this initial outbreak site, 318 individuals were 
infected and 280 of those infected died as a result of the virus. There were 
38 individuals who survived. In 1995, an epidemic of the virus occurred in 
Kikwit, Zaire (Democratic Republic of Congo) and spread to surrounding 
communities. In this incident, 81% of the 318 reported cases resulted in 
death. In the following year, three more outbreaks of the virus occurred. In 
Gabon, Africa, two separate outbreaks occurred. During the first outbreak, 
57% of the 37 cases reported were deaths due to the virus. In the second 
incident, which occurred in the Boue area, 75% of the 60 reported cases were 
deaths due to the virus. The third incident occurred in South Africa in 1996 
where a medical professional was infected. However, the only fatality was 
the nurse who cared for this individual[3]. 
The primary reason for the spread of the epidemic was the close personal 
contact between infected individuals and hospital staff. Also poor hospital 
practices such as the reusage of contaminated needles and syringes added to 
the spread of the disease[3][4]. 
1.4.2 Ebola-Sudan 
Ebola-Sudan is another Ebola sub-type that is deadly to humans and non-
human primates. There were two occurences of Ebola-Sudan in 1976. The 
first in Sudan, Africa where there were 284 reported cases. Of those 284 cases, 
53% died and 133 of them recovered. The disease was spread through close 
personal contacts within a hospital facility. The second incident occurred in 
a single person who accidentally contracted the disease by a contaminated 
needle. This person survived. Lastly, in 1979, there was a third occurence 
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in Sudan, Africa. There were only 34 cases reported. Of those 34 cases, 65% 
died and 12 recovered[3]. 
1.4.3 Ebola-Reston 
According to the Center for Disease Control (CDC), there have been five 
incidents of the Ebola-Reston virus. The first case was recorded in 1989 in the 
United States. The virus was discovered in monkeys at quarantine facilities 
in Virginia, Texas, and Pennsylvania. The monkeys infected with the virus 
were imported from the Philipines. In this incident, four people became 
infected with the virus but they did not become ill. In fact, these individuals 
developed antibodies. The virus reappeared in the facilities in 1990 and four 
humans developed antibodies, but did not get sick. In 1992, monkeys infected 
with Ebola-Reston were imported into the United States from a quarantine 
facility in Sienna, Italy. However, no humans were infected with the virus. In 
1996, infected monkeys imported from the Philipines arrived at a quarantine 
site in Alice, Texas. Again, no humans were infected. This was also the case 
in the latest event that occurred in the Philipines in 1996. The virus was 
identified in monkeys at an export facility[3]. Of all the Ebola-Reston cases, 
there have been no human deaths or cases of clinical illness due to the virus. 
However, researchers have not concluded that humans are immune from the 
virus as further research is necessary[4]. 
1.4.4 Ebola-1 vory Coast (Tai) 
The only case of the Ebola-Ivory Coast strain was documented in 1994. A 
scientist in the Ivory Coast became ill after performing an autopsy on a 
chimp. He was later treated and eventually recovered[4]. 
1.4.5 Purpose 
We are interested in how quarantine, barrier methods used by hospitals and 
clinic personnel to prevent the disease from spreading, affect the spread of 
an epidemic. Also, in looking at two different stages of infection, how do 
individuals in the asymptomatic stage and individuals in the symptomatic 
stage affect the epidemic. We will use deterministic and stochastic models 
to study the behavior of an Ebola epidemic. 
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2 The Model 
The model is represented by the following diagram: 
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Figure 2: The transition diagram. 
where: 
N = total population 
S = susceptible individuals 
11 =infectious individuals with few or no symptoms 
12 = infectious individuals with severe symptoms 
Q = quarantined individuals 
R = recovered individuals 
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The parameters are as follows: 
8 = proportion of infections which lead directly to the symptomatic stage 
( 1 - 8) = proportion of infections which lead to the asymptomatic stage 
a= rate of infection development from (/1) to severe symptoms (12) 
{31 = per capita infectivity rate for asymptomatic infectives 
{32 = per capita infectivity rate for symptomatic infectives 
f = fatality rate 
q = quarantine rate 
p = recovery rate 
The system of differential equations that govern our model are as follows: 
dS 
dt (1) 
Note: Our model does not include any demographics that are unrelated 
to the disease state. There are no births, natural deaths or migration. 
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3 Stability Analysis 
In order to determine the behavior of the epidemic, we must linearize the 
system (1)-(5) at the disease free equilibrium point, (S,O,O,O,R), where Sand 
R are arbitary. There is no endemic equilibrium because there are no natural 
births or deaths in our system, as previously stated. People who leave the 
susceptible class are not replaced. Ro is the number of people that an average 
infective person can infect, out of a susceptible population. It is of major 
importance to determine Ro for our system of differential equations because 
we want to know how the number of infected individuals affect the dynamics 
of Ebola. 
Ro is found using the eigenvalues of the Jacobian of our system of equa-
tions. R0 is a quantity such that when Ro < 1 the real parts of all the 
eigenvalues of the Jacobian matrix are negative. 
When we look at the Jacobian of the 5x5 matrix associated with our sys-
tem of differential equations we get two eigenvalues that are both equal to 
zero. When we have eigenvalues that are equal to zero, no conlusions can be 
drawn and the linearization fails. Therefore, we only look at disease related 
variables and we get a 3x3 matrix. Clearly, we see that one of the eigenvalues 
is -(! + p), a negative eigenvalue. Hence, we are able to reduce the Jacobian 
of the 3x3 matrix to a 2x2 matrix. We calculate the Ro from the following 
matrix at (S,O,O,O,R) using the determinant and trace: 
We are not able to determine any local stability due to the fact that two 
eigenvalues are always 0, but we can use Ro to see if we get an epidemic or 
not. 
The determinant is: 
((1- 8) /31 - (a+ p)][8f32- (! + q + p)]- (a+ 8{31) (1- 8) !32· 
The trace is: 
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(1 - b) {31 - a - p + bf32 - (f + q + p) . 
And our Ro is: 
Ro = (-1 ) {31(1- b)+ [b +_a (1- b)] !32 ( 1 1 ) . a+p a+p +q+p 
Now we'll show what Ro means biologically. A person in 11 infects others 
at rate of {31, leaves 11 at a rate of a+ p. On average a person stays in 11 
an average time of a~p· A proportion of (1 -b) of all people that become 
infected go through 11. So the overall contribution to R0 from the 11 stage 
is a~pf31(1- b). 
A person in h infects others at rate of {32 , leaves 12 at a rate off+ q + p. 
So a person stays in h an average time of !+~+P. A proportion b of all intial 
infectives and a+ of 11 infectives, go through [z. So the contribution to Ro a p 
from the ]z class is [b + a~p(1- b)]f32 J+~+p" 
This gives us the same value of R0 as the one that we calculated from the 
Jacobian of our system of equations if 
Ro = (-1-) {31(1- b)+ [b + _a_(1- b)] f3z (f 1 ) < 1, 
a+p a+p +q+p 
then the two terms must each be less than 1. 
Thus 
( 1 - b) {31 < a + p 
and 
bf3z < (f + q + p) . 
Looking back at our trace:' 
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R0 < 1 also implies that the determinant of the Jacobian is positive, i.e., 
[(1- 8) {31 - (a+ p)][8{32- (f + q + p)]- (a+ 8{31) (1- 8) {32 > 0 
In our system of equations, the disease will always die out, since the individ-
uals who leave the susceptible class are not replaced. We can look at our Ro 
to see if we will have an epidemic or not. 
R0 < 1 tells us that the disease will die out monotonically. 
Ro > 1 tells us that there will be an epidemic, which will eventually die out. 
Having found an expression for R0 , we analized our deterministic model 
to see how our parameters affected the behaviour of Ro. We used data from 
Zaire to estimate values of parameters (other than q), so we could look at Ro 
as a function of quarantine. A graph of this function will show how the value 
of R0 behaves as we increase the quarantine rate. In (Figure 3A) we used 
{32 = 0.33, where {32 represents the infectivity rate for symptomatic infectives. 
We also wanted to see how quarantine would affect the behavior of Ro if 
these symptomatic infectives had a higher infectious rate. In (Figure 3B) we 
used {32 = 1.67 
For (Figure 3A), a low quarantine is sufficient to rapidly decrease R0 to 
a low level. However in (Figure 3B), it takes a higher quarantine rate to 
decrease the value of Ro. Furthermore, the graph of Ro levels off at a higher 
value then (Figure 3A). 
Regardless of the value of {32 , Ro approaches a lower boundary as quar-
antine increases. This lower boundary can be calculated by taking the limit 
of Ro. 
lim Ro = lim (1 - 8)!31 + 8{32 + -c--_{3_2a_,('--1_-_8-'-)--,-
q-+oo q-+oo a + p f + q + p (a + p) (f + q + P) 
The second and third terms approach zero as q -too, so we are left with: 
lim Ro = (1 - 8){31 
q-+oo a+ p 
(6) 
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Example B: The value of !3. is 3.33. 
Figure 3: Ro vs. q 
which is the lower bound. For large q, symptomatic infectives (12) are quar-
antined almost immediately, so the disease is spread only by asymptomatic 
infectives (11). 
Another question of interest is: according to our best fit parameters, what 
is the least quarantine required to stop an epidemic? This question can be 
easily answered by finding the value of q for which Ro has the threshold value 
1. We thus have 
Ro(q) = 1 
q = 3.82 
Which means that on average, an infected individual should spend no more 
than 6 hours in / 2 before being quarantined, so that we could avoid an 
epidemic. 
We want to know what would happen to the population, if the rate at 
which people move from / 1 to / 2 were slow. We plotted R0 as a function of 
a. Here we assumed that the infectious rate {32 is ten times greater than the 
infectious rate {31. All other parameters were kept fixed and we used q = 4 
as our best fit parameters. The graph of this function shows the behavior of 
Ro as a increases. 
The high rate of a actually helps in stopping the disease by both, causing 
people to become severely ill and killing them faster before they spread the 
11 
... 
t 
~.?$ 
.1. .• 
J.. ts 
.1. 
O.?S 
0.$ 
o.ts 
Example C: The value of /3,. is 3.33. 
The value of q is 4. 
Figure 4: R0 vs. a 
disease. Also they will be sent into quarantine faster. Thus, reducing the 
number of susceptibles that become infected. As a decreases, the lower 
boundary of Ro approaches and becomes greater than 1. 
So, if someone were to vaccinate or provide treatment that would decrease 
the rate of a to a proportion of a population that is not infected, then we 
would have a higher chance of an occurence of an epidemic. We calculated 
the value of a for which R0 is equal to 1. 
Ro(a) = 1 
a= 0.28 
Which means that on average, the maximum amount of time an individual 
should remain in 11 is about three and a half days. 
3.1 Stochastic Simulations 
Since our model is an attempt to describe the behavior of the Ebola virus 
in a given population, it is important to examine each of the classes as time 
progresses, and make comparisons. A good approach to this is the use of 
computer simulations. Using a computer program(see appendix), we are 
able to study how the different classes are affected when the disease enters 
the system. Before running the simulations, we must first assign values to 
our parameters. The important parameters were varied, while the others 
were kept fixed. We had several extended discussions on what the range of 
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the values should be and arrived at the following conclusions. 
Based on information from the CDC and the World Health Organization 
(WHO), we deduced the value of the fatality rate to be approximately: 
1 f =- = 0.33 
3 (7) 
which means that on average, it will take a person (3) days to die. Further-
more, the virus has the capacity to kill between 50% and 90% of the infected 
individuals. An infected individual can either recover or die, so we solve for 
the recovery rate using the following equation: 
f f + p = 0.9. (8) 
Therefore, p = 0.037. 
We also deduced that there is a higher probability that susceptible indi-
viduals (S) will move into the (/2) class, rather than moving into the (II) 
class. From this we appproximated 8 = 0.75 
From our observations we noted that 90% of the individuals in (II) move 
into (12), while the remaining 10% recover. 
This number is denoted by the following equation: 
a 
--=0.9. 
a+p 
(9) 
We can solve for (a) which is the average rate, per days, an individual will 
remain in the II class before bing removed to the /2 class. We obtain 
(10) 
Quarantine and other barrier methods are policies that are commonly 
used to prevent further spread of the Ebola virus. We will vary the quarantine 
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rate to determine wether or not it will affect the behavior of the virus in a 
given population. These are a range of values for (q) that we decided to test: 
q = .5, 1,4. (11) 
We assume that {31 < {32 because people in (!2) are more infectious than 
people in (!1 ). Thus a rate of one-third was chosen to show that one person 
gets infected by an individual from (!1) every three days. That is, 
{31 = 0.33. (12) 
Based on our assumptions above, {32 should be represented as a multiple 
of {31 . Therefore {32 = k{31 where k = 2, 5, 10. Hence: 
(13) 
4 Results and Discussion 
According to our deterministic graphs, it would be disastrous if a popula-
tion where given a vaccine or drug that would decrease the a rate. We have 
seen that as a decreases the value of R0 increases. We calculated that the 
maximum amount of time that a person should remain in 11 should be, on 
average, about three and a half days. If on average, individuals are spending 
a longer time in the 11 stage then we will have an epidemic. 
We also plotted the graph of Ro as a function of q and we saw the be-
havior of Ro as quarantine increased. Again we noted that as we increased 
quarantine, Ro would decrease. We calculated that on average, the maxi-
mum amount of time it would take to quarantine someone, if we would like 
to stop an epidemic, is about twelve hours. 
The 11 class is very important in our model. At a high rate of quarantine, 
we are able to stop the virus from spreading within the 12 class but not from 
the 11 class. So if the 11 class is very large, we can have an epidemic even 
at a high quarantine rate. Unfortunately, it is very difficult to diagnose the 
individuals in h as these individuals are in the asymptomatic stage. 
The difference between {31 and {32 has a great affect on the epidemic size. 
The epidemic size changes as {32 changes. That is, the higher the rate of in-
fection of individuals in 12 , the larger the epidemic. Therefore it's important 
to quarantine these individuals at a high rate to help reduce the epidemic 
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size. 
When we increase the quarantine rate q, the epidemic size decreases sig-
nificantly. Even though we increased the quarantine rate, this has no effect 
on the latency of the epidemic, it lasted approximately the same amount of 
time. When we increased the quarantine rate, less people died. In conclu-
sion, if the infectious rate of people in ! 2 is very large, then no matter how 
high the rate of quarantine the epidemic size will remain the same. 
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7 Appendix 
7.1 Computer Simulations 
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These histograms correspond with our stochastic simulation data. As you 
can see, the epidemic size decreases as you increase quarantine. 
However, the mean time to extinction stays the same. 
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7.2 Computer Algorithm 
function initrnd 
% Initrnd.m 
% seed the random number generator 
rand('state',sum(100*clock)); 
function eventtype=wheel(eventlist) 
% evetytype=wheel(eventlist) 
% returns the type of event from list of rates 
picker=cumsum(eventlist)/sum(eventlist); 
eventtype=sum(picker<rand)+1; 
function ebola6(sO,i1,b1,i2,b2,tran,sick,r,q,f,T,sim) 
% ebola6(s0,i1,b1,i2,b2,tran,sick,r,q,f,T,sim) 
% Simulates a simple SIIQR model 
% sO initial suscep. pop. 
% i1 initial infected w/o symptoms 
% b1 infectious coeficient rate 
% i2 initial infected w/symptoms 
% b2 infectious coeficient w/symptoms 
% tran rate from S to I1 
% sick rate at which infected becomes very infectious 
% r recovery rate 
% q quarantine rate 
% f fatality rate 
% T is max time 
% sim max number of simulations 
tic; 
initrnd; 
figure(!); %clear figures 
elf; 
figure(2); 
elf; 
hold off; 
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for simul = 1:sim 
S=sO; % initial value 
I=i1; 
I2=i2; 
Re=O; 
Qt=O; 
t=O; % initial time 
%initial population at start of epidemic for given simulation 
NO=sO+i1+i2+Re+Qt; Nplot=[S,t,I,I2,Re,Qt]; 
while (t<T) & (I+I2>0); 
N=S+I+I2+Re+Qt; 
%finds next event time 
nextt=-log(rand)/(((1-tran)*(bl*S*I/(N-Qt)))+ 
(tran*(b2*S*I2/(N-Qt)))+(sick*I)+(r*I)+ 
(q*I2)+(f*I2)+(r*I2)+(r*Qt)+(f*Qt)); 
t=t+nextt; %calculate next time 
%event doesnt occur til t, N rem. cons. til t. 
Nplot=[Nplot; [S,t,I,I2,Re,Qt]]; 
event=wheel([(1-tran)*b1*S*I/(N-Qt),tran*b2*S*I2/(N-Qt), 
sick*I,r*I,q*I2,f*I2,r*I2,r*Qt,f*Qt]); %choose event 
if event==! 
S=S-1; 
I=I+1; %infection 
elseif event==2 
S=S-1; 
I2=I2+1; %recovery 
elseif event==3 
I=I-1; 
I2=I2+1; 
elseif event==4 
I=I-1; 
Re=Re+1; 
elseif event==5 
I2=I2-1; 
Qt=Qt+1; 
elseif event==6 
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end 
I2=I2-1; 
elseif event==7 
I2=I2-1; 
Re=Re+1; 
elseif event==8 
Qt=Qt-1; 
Re=Re+1; 
elseif event==9 
Qt=Qt-1; 
end 
Nplot=[Nplot; [S,t,I,I2,Re,Qt]]; %next point 
[simul,t]; %displays the time, semicolon to turn off 
%plot the total epidemic size, succeptibles, recovered and quarantined 
%after every simulation to get a matrix 
A(simul,:)=[NO-S,S,t,Qt,NO-N,Re]; 
%* for deterministic model comparison *% 
figure(1) % this figure will hold the time plots 
hold on; %superimpose time plots 
plot(Nplot(:,2),Nplot(:,1)); %plot suceptibles with a blue line 
plot(Nplot(:,2),Nplot(:,3), 'r-'); %plot infecteds(I1) with a red line 
plot(Nplot(:,2),Nplot(:,4), 'g-'); %plot infecteds(I2) with a green line 
plot(Nplot(:,2),Nplot(:,5), 'c-'); %plots recovered with a cyan line 
plot(Nplot(:,2),Nplot(:,6), 'k-'); %plots quarantined with a black line 
title('Blue=(S), Red=(I1), Green=(I2), Black=(Q)') 
ylabel('The Population of (S),(I1),(I2),(Q),(R)') 
xlabel('Time (days)') 
zlabel('test') 
if toe >5 
[simul,t] %displays the, time semicolon to turn off 
tic; 
end; 
end 
%* for deterministic model comparison *% 
if sim > 1 %only draw the histogram if there is more than 1 simulation 
21 
.. 
figure(2); 
hold off; %erases any previous histograms 
figure(2); 
%title('Distribution of the population') 
%title('Epidemic Size, Susceptibles, Mean time to Extinction') 
subplot(3,1,1) 
hist(A(:,1)); 
subplot(3,1,2) 
hist (A (: , 2)) ; 
subplot(3,1,3) 
hist(A(: ,3)); 
figure(3); 
%title('Distribution of the population') 
%title('Quarantined, Fatalities, Recovered') 
hold off; %erases any previous histograms 
figure(3); 
subplot(3,1,1) 
hist(A(: ,4)); 
subplot(3,1,2) 
hist(A(: ,5)); 
subplot(3,1,3) 
hist(A(: ,6)); 
end 
Meanx1 = [mean(A(: ,1)),mean(A(:,3)),mean(A(:,5))] 
Stdx1 = [std(A(:,1)),std(A(:,3)),std(A(:,5))] 
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